Download PDF
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Direct-acting antiviral agents and risk of Hepatocellular carcinoma: Critical appraisal of the evidence
Ciro Celsa; Caterina Stornello; Paolo Giuffrida; Carmelo Marco Giacchetto; Mauro Grova; Gabriele Rancatore; Concetta Pitrone; Vito Di Marco; Calogero Cammà; Giuseppe Cabibbo;
Ann Hepatol. 2022;27 Supl 1:
Trends and health inequalities of hepatitis virus-associated liver cancer mortality during 1990¿2050
Yujiao Deng; Jingyue Tan; Jian Zu; Zixuan Xing; Zhanpeng Yang; Yue Zhang; Yajing Bo; Xu Gao; Enrui Xie; Yuan Wang; Meijuan Han; Fanpu Ji; Yang Yang;
Ann Hepatol. 2026;31:
Situational panorama of chronic liver diseases: A single-center experience at a University Hospital in northeast Mexico (1995¿2019)
Paula Cordero-Perez; Liliana Torres-González; Samuel Rivas-López; Carolina Treviño-García; Airam Regalado-Ceballos; Jaime R. Zúñiga-Noriega; Ingrid G. López-Reyna; Luz M. Barbosa-Castillo; Isai E. Hernández-Padilla; Linda E. Muñoz-Espinosa;
10.1016/j.aohep.2025.102116